The Equal Access to Contraception for Veterans Act amends 38 U.S.C. §1722A(a)(2) to limit copayments the Department of Veterans Affairs may charge for contraceptive medications and items. It adds two explicit caps: VA may not charge veterans more than the Secretary’s acquisition cost for certain contraceptive medications, and it may not impose any copayment for contraceptive items that federal law requires insurers to cover without cost-sharing under the Affordable Care Act (ACA).
The change is narrowly targeted at VA copay policy but has practical implications for veterans’ out‑of‑pocket costs, VA pharmacy revenue and billing operations, and how the VA aligns benefits with federal preventive‑service rules. The bill does not appropriate funds or outline enforcement procedures, leaving implementation details to the Secretary and VA systems.
At a Glance
What It Does
The bill inserts two subparagraphs into 38 U.S.C. §1722A(a)(2): (A) prohibits copays that exceed the Secretary’s cost for specified contraceptive medication; and (B) bars any copayment for contraceptive items that the Public Health Service Act §2713(a)(4) requires insurers to provide without cost-sharing.
Who It Affects
Directly affects VA patients receiving contraceptive medications or devices and VA pharmacy and billing operations; indirectly affects VA community care providers, pharmacy contractors, and federal benefit administrators reconciling VA and ACA coverage rules.
Why It Matters
It aligns VA copayment policy with ACA preventive-service coverage and caps out-of-pocket charges at the VA’s own acquisition cost, reducing financial barriers for veterans while raising questions about VA revenue, program administration, and how 'cost to the Secretary' will be calculated.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
This bill makes a surgical change to statutory language governing copayments for drugs and items furnished through the Department of Veterans Affairs. It does not create a new benefit; rather, it sets firm limits on what the VA may collect from veterans for contraceptive products.
First, for contraceptive medications identified in the existing paragraph (1) of the statute, the VA may not charge veterans more than the amount it paid to obtain the medication — in short, no markup above VA’s own cost. Second, for contraceptive items that federal law — specifically the ACA preventive‑services rule codified at 42 U.S.C. 300gg‑13(a)(4) — requires private insurers to cover without cost-sharing, the VA may not impose any copayment.
Because the bill amends an existing copayment provision rather than adding a standalone entitlement, the Secretary retains discretion over operational details: how to implement billing changes, which specific contraceptive items fall within the prohibition, and whether certain services (counseling, insertion/removal of devices) are included. The text does not change copayment rules for noncontraceptive medications or services, nor does it include appropriations or specify penalties for noncompliance.Practically, VA pharmacies, third‑party administrators, and community providers will need to reconcile VA copay schedules with the bill’s limits.
The VA will also have to define “cost to the Secretary” for this purpose (acquisition price only, acquisition plus dispensing fees, or another metric) and map ACA preventive‑service categories to VA benefit codes. That operational work will determine how much veterans’ out‑of‑pocket spending actually falls as a result of this statutory cap.
The Five Things You Need to Know
The bill amends 38 U.S.C. §1722A(a)(2) by adding two new subparagraphs labeled (A) and (B).
Subparagraph (A) bars VA copayments that exceed the Secretary’s cost for the contraceptive medication described in the statute’s paragraph (1).
Subparagraph (B) prohibits any copayment for contraceptive items that the Public Health Service Act §2713(a)(4) requires to be covered without cost-sharing under the ACA.
The statutory change is limited to copayment amounts; it does not create a separate entitlement, appropriate funds, or establish enforcement procedures.
The bill leaves undefined key implementation terms — notably what counts as the Secretary’s 'cost' and which contraceptive items the VA will treat as subject to the ACA no‑cost‑sharing requirement.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title — Equal Access to Contraception for Veterans Act
This is the act’s caption; it does not affect benefits or implementation. Naming the bill signals legislative intent but carries no operative effect on rights, copay amounts, or VA procedures.
Caps and exclusions on VA contraceptive copayments
Section 2 performs the substantive change: it replaces the existing tail of §1722A(a)(2) with language that (A) prevents the VA from charging more than the Secretary’s cost for certain contraceptive medications and (B) forbids any copayment for contraceptive items that federal law (PHSA §2713(a)(4)) requires insurers to provide without cost-sharing. Practically, this directs the VA to adjust copayment schedules and billing rules for contraceptives while leaving the rest of the copayment framework in place.
Implementation responsibilities left to the VA
The amendment contains no definitions, implementation timeline, appropriation, or enforcement mechanism. That means the VA must translate statutory limits into operational policy: decide how to calculate the 'cost to the Secretary' (e.g., acquisition price vs. acquisition plus dispensing/admin fees), identify which contraceptive items align with the ACA preventive coverage list, and update pharmacy, claims, and community care billing systems to prevent over‑charging.
This bill is one of many.
Codify tracks hundreds of bills on Veterans across all five countries.
Explore Veterans in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Reproductive‑age veterans who use VA pharmacies — they will face lower or zero copayments for covered contraceptive medications and items subject to the ACA preventive‑service rule.
- Low‑income veterans and veterans with limited prescription coverage — removing or capping copays reduces a financial barrier that can drive nonuse or gaps in contraceptive care.
- Veterans relying on community‑provided contraceptive services paid or coordinated by VA — aligning VA copay policy with ACA no‑cost‑sharing categories can reduce unexpected charges when care is delivered outside VA facilities.
Who Bears the Cost
- VA medical centers and the Veterans Health Administration — potential loss of copay revenue for contraceptives and administrative costs to update billing systems and policies.
- VA pharmacy benefit managers, contractors, and community providers — they will need to modify claims processing and reimbursement workflows to comply with new copay limits.
- Congress and federal budget authorities — if reduced copay recoveries materially affect VA budgets, appropriators may face pressure to cover shortfalls or reallocate funds to maintain pharmacy operations.
Key Issues
The Core Tension
The bill forces a trade‑off between improving veterans’ affordable access to contraception and shifting financial and administrative burdens onto the VA system: guaranteeing lower out‑of‑pocket costs without specifying funding or operational rules resolves the access problem in statute but creates ambiguity about who pays and how the VA will implement the rule in practice.
The bill’s simplicity is both its strength and its principal implementation headache. It fixes statutory maximums for contraceptive copays but does not specify the accounting rules necessary to apply those caps in a complex pharmacy ecosystem. 'Cost to the Secretary' can be interpreted several ways: acquisition invoice price, acquisition plus dispensing fees, or a full cost allocation that includes overhead.
Each choice produces different fiscal and access outcomes. Without a definition, the Secretary’s forthcoming regulatory or policy guidance will determine how meaningful the cap is in practice.
A second tension concerns the ACA reference. The bill imports the preventive‑service categories of PHSA §2713(a)(4) but does not list items or modalities.
The ACA preventive list has been interpreted to include a broad range of contraceptive drugs, devices, and related services; however, mapping those categories to VA benefit codes and community‑care billing requires operational work and could produce disputes over whether a particular device, insertion service, or long‑acting reversible contraceptive is copay‑free. Finally, the statute does not provide additional funding for increased utilization, administrative changes, or potential revenue shortfalls, nor does it specify audits, penalty structures, or remedies for veterans who were overcharged before implementation.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.